These medications mimic the action of naturally occurring GLP-1, an incretin hormone released by the intestine in response to food intake
Weight Loss Results: Head-to-Head Data Semaglutide Clinical Trial Results The STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the most comprehensive dataset for any anti-obesity medication: STEP 1 (Wilding et al., 2021, NEJM ): 1,961 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Semaglutide 2.4 mg weekly vs
CMS originally planned a longer-term follow-on program called the BALANCE Model for Medicare Part D starting in 2027, but that launch has been delayed
Whether you're looking to boost your energy, enhance your skins glow, support your immune system, or recover after a busy lifestyle, JoJoHatley IV Fusion Drips provide a tailored solution to meet your wellness needs
Zepbound tackles an underlying cause of excess weight
Current research continues to explore its potential role within targeted, mechanism-driven PCOS management strategies